Medical Device Safety Consulting | Dr. Selim Bordany, MD PhD
Regulatory‑grade safety strategy • EU MDR • PMS/PSUR

Safety that accelerates approvals — and stands up to audits.

I help device companies design, document, and defend safety across the product lifecycle: from risk management and CER/PMCF to vigilance and health‑authority queries. Fast, rigorous, and inspection‑ready.

Device Risk Management (ISO 14971) • Hazard analysis, FMEA/FMECA, risk controls
EU MDR Clinical Evaluation (CER) & PMCF plans/reports • PSUR & PMS
<极>Device Vigilance • MAUDE trending • HAQ/deficiency responses
Clinical Safety Governance • DSMB/SMT • AE/SAE medical review & narratives
Trusted by teams delivering biologics, combination products, and implantables
Dr. Selim Bordany
15+ years in safety Spine & biologics Global submissions

Selected impact

  • Led vaccine safety surveillance generating 7,000‑page submissions for regulators.
  • Safety lead for Medtronic spine devices & adjunct biologics; ran RCT medical safety and post‑market vigilance.
  • Created a consolidated CER model that cut resource use by ~65% and streamlined renewals.
  • Implemented reporting protocols saving ~$1.5M annually while improving time‑to‑signal.
Audit‑ready documentation • Cross‑functional leadership • Rapid turnarounds

What I do

Clear deliverables, clear timelines.

Risk Management

Risk policy, risk management plan, hazard analysis, FMEA/FMECA, and risk‑benefit.

EU MDR Clinical Evaluation

CER authoring/updates (MEDDEV 2.7/1 rev.4 & MDR Annex XIV), literature plans/reviews, PMCF plans/reports.

Post‑Market Surveillance

PMS reports, PSUR, signal detection and management, benefit‑risk updates, MAUDE/EUDAMED trending, customer complaint analytics.

Vigilance & Field Actions

Serious incident assessment, Impact Issue Assessment (IIA), reportability decisions, narratives, and FSCA communications support.

HAQ/Deficiency Responses

Rapid, evidence‑based responses to FDA/Notified Body questions; gap remediation plans and traceability mapping across QMS, RMF, CER, and IFU.

Clinical Safety Governance

Safety monitoring (AE/SAE medical review), DSMB/S极MT charters, protocol safety language, investigational plan inputs for combination products.

Client Success Stories

What medical device professionals say about working with me

Dr. Bordany transformed our risk management documentation, making it audit-ready in just three weeks. His expertise in both clinical and technical aspects is exceptional.

Sarah J., Regulatory Director
Cardiac Device Manufacturer

We were struggling with MDR compliance until we engaged Dr. Bordany. His CER and PMCF strategies were exactly what we needed for notified body approval.

Michael T., Quality VP
Orthopedic Implants

His vigilance system implementation not only improved our compliance but saved us significant resources. The ROI was evident within the first quarter.

Lisa R., CEO
Diagnostics Startup

Trusted By Industry Leaders

Partnering with innovative companies across the healthcare spectrum

A simple, high‑conversion engagement process

Built to minimize your effort and maximize regulatory readiness.

1

FREE Discovery

30‑min intake to map device, claims, markets, timelines, and pain points. NDA available.

2

Rapid Assessment

Gap review across RMF/CER/PMS, producing a red‑yellow‑green scorecard and prioritized actions.

3

Remediation Sprints

Fixed‑fee sprints for each deliverable (e.g., CER update + PMCF plan) with weekly check‑ins and version control.

Outcomes & proof

Global vaccine surveillance

Led one of the largest vaccine safety programs; authored multi‑thousand‑page submissions and navigated complex health‑authority interactions.

Spine devices & biologics

Medical safety lead for implantables and rhBMP‑based adjuncts; ran RCT safety and scaled post‑market vigilance programs.

Efficiency, not just compliance

Consolidated CER approach cut resource use ~65%; revamped reporting processes saved ~$1.5M/year while improving oversight.

FAQ

Can you take over our CER/PMCF on short notice?

Often, yes. The discovery + rapid assessment phases are designed to triage quickly, then we execute sprints focused on highest‑risk gaps first.

What markets and device classes?

EU MDR and FDA for implantables, active devices, and combination products across Class I–III (US) / Class I–III (EU).

How do you handle confidentiality?

Mutual NDAs and secure collaboration (version control, auditable edits, restricted access). I can work within your DMS or set up a dedicated workspace.

Do you work with Notified Bodies directly?

Yes, I prepare responses and support during audits to ensure your documentation meets all regulatory requirements.

Let’s talk about your device

Send a quick note with your device type, market(s), and target timeline.

All guidance is provided for regulatory and scientific purposes and does not constitute legal advice.

© Dr. Selim Bordany, MD PhD • Medical Device Safety Consulting
EU MDR • CER/PMCF • PSUR/PMS • Vigilance • HAQs